Ruth Heying

Ruth Heying

Auto-generated profile, based on publicly available information

Ruth Heying

UZ Leuven

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2012 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
RHRuth Heying
Ruth Heying
EWEdith Wehage
Edith Wehage
KSKatharina Schumacher
Katharina Schumacher
PTPeter Tassani
Peter Tassani
FHFelix Haas
Felix Haas
MSMarie-Christine Seghaye
Marie-Christine Seghaye

17 June 2018 in Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
JCJorien Claes
Jorien Claes
BDBartosz Ditkowski
Bartosz Ditkowski
LLLaurens Liesenborghs
Laurens Liesenborghs
TVTiago Rafael Veloso
Tiago Rafael Veloso
JEJose M. Entenza
Jose M. Entenza
RHRuth Heying
Ruth Heying
Adhesion of Staphylococcus aureus to endothelial cells (ECs) is paramount in infective endocarditis. Bacterial proteins such as clumping factor A (ClfA) and fibronectin binding protein A (FnbpA) mediate adhesion to EC surface molecules and (sub)endothelial matrix proteins including fibrinogen (Fg), fibrin, fibronectin (Fn) and von Willebrand factor (vWF). We studied the influence of shear flow and plasma on the binding of ClfA and FnbpA (including its sub-domains A, A16+, ABC, CD) to coverslip-coated vWF, Fg/fibrin, Fn or confluent ECs, making use of Lactococcus lactis, expressing these adhesins heterologously. Global adherence profiles were similar in static and flow conditions. In the absence of plasma, L. lactis-clfA binding to Fg increased with shear forces, whereas binding to fibrin did not. The degree of adhesion of L. lactis-fnbpA to EC-bound Fn and of L. lactis-clfA to EC-bound Fg, furthermore, was similar to that of L. lactis-clfA to coated vWF domain A1, in the presence of vWF-binding protein (vWbp). Yet, in plasma, L. lactis-clfA adherence to activated EC-vWF/vWbp dropped over 10 minutes by 80% due to vWF-hydrolysis by a disintegrin and metalloproteinase with thrombospondin type 1 motif, member 13 and that of L. lactis-fnbpA likewise by > 70% compared to the adhesion in absence of plasma. In contrast, plasma Fg supported high L. lactis-clfA binding to resting and activated ECs. Or, in plasma S. aureus adhesion to active endothelium occurs mainly via two complementary pathways: a rapid but short-lived vWF/vWbp pathway and a stable integrin-coupled Fg-pathway. Hence, the pharmacological inhibition of ClfA-Fg interactions may constitute a valuable additive treatment in infective endocarditis. M.H., R.H., B.D., T.V., L.L., T.R.V. and P.V. designed the research. J.C. and B.D. performed the experiments and analysed the data. J.C., B.D., M.H. and R.H. wrote the manuscript. P.M. and J.M.E. designed the research and provided the L. lactis strains. B.D. performed all work of the revision. * Bartosz Ditkowski performed all the experimental work during the revision and drafted the revised manuscript.

19 February 2011 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
UUUrso Urso
Urso Urso
FRFilip Rega
Filip Rega
BMBart Meuris
Bart Meuris
MGMarc Gewillig
Marc Gewillig
BEBenedicte Eyskens
Benedicte Eyskens
BMBart Meyns
Bart Meyns
Objective: A large spectrum of congenital heart diseases requires valved conduits to establish an anatomical continuity between the right ventricle outflow tract (RVOT) and the pulmonary artery. The aim of the present study was to compare the incidence of graft replacement in patients receiving the Contegra conduit (bovine jugular vein graft) with that in patients receiving a homograft implanted in the RVOT. Methods: We reviewed a total of 347 conduits (Contegra 54; homografts 293) implanted in the RVOT from 1989 to 2003 in 323 patients (median age 12.7 years, range 4 days–69 years). Indications were Tetralogy of Fallot (n = 148), Ross operation (n = 89), truncus arteriosus communis (n = 47), pulmonary valve atresia (n = 30), double-outlet right ventricle (n = 15), transposition of the great arteries (n = 12), and endocarditis (n = 6). Follow-up was 99.4% complete (mean time: 5.9 years; range: 0–14.2 years). Results: Freedom from graft replacement at 1, 5, and 10 years of follow-up in the Contegra and homograft groups were 98.1 ± 1.9%, 78.3 ± 5.8%, and 63.5 ± 7.2% and 99.6 ± 0.4%, 94.0 ± 1.6%, and 81.4 ± 3.4%, respectively (log-rank test, p ≪ 0.001). Independent predictors of graft replacement of the whole sample population were: graft size ≤ 20 mm (hazard ratio (HR) 3.6), age ≤ 10.4 years (HR 3.0), the non-anatomical position of the graft (HR 2.9), and the use of the Contegra conduit (HR 2.5). The multivariable analysis carried out on the propensity-score-matched population confirmed three independent predictors of graft replacement: graft size ≤ 20 mm (HR 8.0), the non-anatomical position of the graft (HR 2.3), and the use of the Contegra conduit (HR 3.7). Conclusions: Besides size of the graft, age of the patients, and the non-anatomical position of the graft, the use of the Contegra conduit was found to be an independent risk factor for graft replacement in the RVOT. Patients receiving this conduit were more than twice as likely to undergo re-operation for graft replacement as those receiving a homograft.

15 June 2017 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
TVTiago Rafael Veloso
Tiago Rafael Veloso
JCJorien Claes
Jorien Claes
SKSoetkin Van Kerckhoven
Soetkin Van Kerckhoven
BDBartosz Ditkowski
Bartosz Ditkowski
LHLuis G. Hurtado-Aguilar
Luis G. Hurtado-Aguilar
RHRuth Heying
Ruth Heying

1 December 2012 in Acta Cardiologica
Verified
Journal Article
Closed access
SBStephen C. Brown
Stephen C. Brown
FDFcpaed Dch
Fcpaed Dch
MLMark De Laat
Mark De Laat
MPMarijka Proesmans
Marijka Proesmans
KBKris De Boeck
Kris De Boeck
MGMarc Gewillig
Marc Gewillig
Background The ideal treatment strategy for pulmonary sequestration whether resection or embolization in childhood is not clearly defi ned. Our institution has no clear policy, therefore both therapies are performed. Objective The aim of this study was to assess local management strategies of children presenting with pulmonary sequestrations. Methods This is a retrospective, single-institutional review. The main inclusion criterion was the established diagnosis of a pulmonary sequestration. Forty-eight patients were divided into three groups based on treatment received: conservative management (n = 5), surgery (n = 22) and embolization (n = 21). Results The median age at treatment was 8.0 months (range 1.2 – 166.0) in the surgical, 4.0 months (range 0.2 – 166.0) in the embolization and 8 months (range 0.3 – 197.0) in the conservatively managed groups, respectively. Age at treatment was similar in the surgical and embolization groups (P = 0.9). Recurrent chest infections were the most common clinical presentation in the surgical group, whilst cardiac failure was the most frequent symptom in the embolization group (P < 0.01; 95% CI: 0.3 to 0.9). There were six complications in the surgical group and one in the embolization group (P = 0.1). In one patient embolization was not possible. Outcomes in both groups were comparable with good results on follow-up. Conclusion Both surgery and endovascular embolization are eff ective and safe treatments for pulmonary sequestration. The presenting symptoms dictate therapy: surgery if there is infection and embolization if a shunt needs to be abolished. Our institutional policy remains unchanged.

12 April 2021 in Cardiology in the Young
Verified
Journal Article
Open access
PDF file
CMColin J. McMahon
Colin J. McMahon
JTJustin Tretter
Justin Tretter
ARAndrew N. Redington
Andrew N. Redington
FBFrances Bu’lOck
Frances Bu’lOck
LZLiesl Zühlke
Liesl Zühlke
JWJonathan D. Windram
Jonathan D. Windram
Despite enormous strides in our field with respect to patient care, there has been surprisingly limited dialogue on how to train and educate the next generation of congenital cardiologists. This paper reviews the current status of training and evolving developments in medical education pertinent to congenital cardiology. The adoption of competency-based medical education has been lauded as a robust framework for contemporary medical education over the last two decades. However, inconsistencies in frameworks across different jurisdictions remain, and bridging gaps between competency frameworks and clinical practice has proved challenging. Entrustable professional activities have been proposed as a solution, but integration of such activities into busy clinical cardiology practices will present its own challenges. Consequently, this pivot towards a more structured approach to medical education necessitates the widespread availability of appropriately trained medical educationalists, a development that will better inform curriculum development, instructional design, and assessment. Differentiation between superficial and deep learning, the vital role of rich formative feedback and coaching, should guide our trainees to become self-regulated learners, capable of critical reasoning yet retaining an awareness of uncertainty and ambiguity. Furthermore, disruptive innovations such as “technology enhanced learning” may be leveraged to improve education, especially for trainees from low- and middle-income countries. Each of these initiatives will require resources, widespread advocacy and raised awareness, and publication of supporting data, and so it is especially gratifying thatCardiology in the Younghas fostered a progressive approach, agreeing to publish one or two articles in each journal issue in this domain.